2024 Liquid Biopsy Market Insights: Cancer, Usage, Biomarkers, Product Pricing, and Volume Trends 2023-2027
The report on “Liquid Biopsy Markets by Cancer, Usage, Biomarker, Place, & Product with Price and Volume Outlook, including Executive and Consultant Guides, and Customized Forecasting and Analysis for 2023-2027” is now available through ResearchAndMarkets.com. This report provides a comprehensive…
ICUS Backs Sonographers’ Expanded CEUS Role
The International Contrast Ultrasound Society (ICUS) has announced that the expanding role of sonographers will provide more patients with access to safe and affordable diagnostic scans known as “contrast-enhanced ultrasound” (CEUS). ICUS, a worldwide medical society dedicated to promoting the…
US IVD Market Analysis 2023-2030: Advancing Tech Drives Adoption & Fuels Demand
The report titled “United States In-Vitro Diagnostics Market Analysis 2024-2030: Industry Trends, Growth, Share, Outlook, and Opportunity Company Analysis” has been included in ResearchAndMarkets.com’s offerings. The United States In-Vitro Diagnostics (IVD) Market is projected to reach approximately US$ 56.52 Billion…
GE HealthCare to Showcase Precision Care Technologies in Interventional Radiology at SIR 2024
GE HealthCare (Nasdaq: GEHC) is set to exhibit its cutting-edge technologies in image guiding solutions, surgery, ultrasound, and CT-navigation at the upcoming 2024 Society of Interventional Radiology (SIR) Annual Scientific Meeting from March 23-28 in Salt Lake City, UT. The…
Global Balloon Catheter Market Analysis 2023-2030: Minimally Invasive Solutions and Cardiovascular Demand
The “Global Balloon Catheter Market Forecast 2024-2030: Industry Trends, Growth, Share, Company Analysis” now available on ResearchAndMarkets.com The Global Balloon Catheter Market is Projected to Reach Nearly US$ 7 Billion by 2030 The global market for balloon catheters is expected…
Holly Werkema of Baron & Budd Wins 2024 Compassionate Counsel Award
Baron & Budd, P.C., a national law firm, is delighted to share that shareholder Holly Werkema has been selected for the 2024 Compassionate Counsel Award. This prestigious honor is bestowed each year by The Milestone Charitable Foundation on a distinguished…
Global Skull Clamp Market Analysis Report Now Available
The report titled “Global Skull Clamp Market: Product, Application, Material, Accessories, End User, Regional Analysis, COVID-19 Impact, and Forecast 2029” is now available on ResearchAndMarkets.com. The global market for skull clamps reached a value of US$2.21 billion in 2023 and…
MSAA Chooses SEQSTER for Patient-Centric Innovation
SEQSTER PDM Inc. (SEQSTER), a leading patient-centric healthcare technology company, has been chosen by the Multiple Sclerosis Association of America (MSAA) for its patient-centricity, 1-Click Records™, and advanced longitudinal health record. SEQSTER brings together individuals living with multiple sclerosis (MS),…
Dr. Gary K. and Alya Michelson Honored with 2024 Humanitarian Award
Dr. Gary K. Michelson and Alya Michelson were honored with the 2024 Humanitarian Award at the World Brain Mapping Foundation’s 21st Gathering for Cure (GFC) Awards Gala held at the Biltmore Hotel in Los Angeles. The prestigious award recognizes individuals…
Pramana’s Digital Pathology 2.0 Milestone
At the USCAP annual conference in Baltimore, MD, from March 25-28, 2024, Pramana, Inc. will exhibit its advanced solutions for Digital Pathology 2.0 at booth #549. Pramana will showcase its vast experience and cutting-edge technologies, such as the development of…
SSO 2024: Low-Risk DecisionDx®-Melanoma Test Results Recurrence-Free at 3 Years
Castle Biosciences, Inc. (Nasdaq: CSTL), a company focused on improving patient care through innovative tests, has announced the presentation of new data showcasing the performance of its DecisionDx-Melanoma test in predicting the risk of sentinel lymph node (SLN) positivity in…
Positive CHMP Opinions for Bempedoic Acid in Hypercholesterolemia
Daiichi Sankyo Europe GmbH and Esperion Therapeutics, Inc. have made a joint announcement regarding the recent developments related to bempedoic acid (marketed as NILEMDO®) and the bempedoic acid/ezetimibe fixed combination tablet (marketed as NUSTENDI®) in the European market. The Committee…